Describe the pathophysiology of hypercholesterolemia, including risk assessment and preventive strategies for cardiovascular disease. |
|
|
|
|
|
|
Examine clinical trial data for emerging PCSK9 inhibitors for the treatment of dyslipidemia presented at ESC 2016. |
|
|
|
|
|
|
Integrate new data into individualized treatment plans to improve and maintain outcomes for patients with dyslipidemia. |
|
|
|
|
|
|